SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Dynavax DVAX -- Ignore unavailable to you. Want to Upgrade?


To: Savant who wrote (123)6/3/2017 5:12:39 PM
From: scaram(o)uche  Respond to of 184
 
So... up 4%, regular hours, another 20% after hours. More action, Monday morning?? ASCO report, small n.

Gorgeous early data, but.... nine patients.

I saw the report, and tried to go overweight. Bought first slug at 6.25, and then accidentally sold it, wide bid/ask differential, while thinking I was buying a second. First time I've made that mistake in decades. Was down a few % trading, with only my original stake, when I thought I had two of three slugs toward an overweight.

:-(

Recovered, bought another slug, and sold 40% of that just before 8 pm Eastern. Turned a massive profit into a modest win. Ugh. Hope you have some.



To: Savant who wrote (123)4/2/2019 2:11:24 PM
From: tuck  Respond to of 184
 
But TLR9 + Nivolumab (anti-PD-1) whiffs in NSCLC, per data at AACR. Perceived as longshot program by market, so little share price data.

Cheers, Tuck